Skip to main content

Table 2 Pre-booster anti-HBs titer by vaccine group.

From: A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

Anti-HBs titer (mIU/ml)

Group 1 (N = 113) Hexavac® n (%)

Group 2 (N = 124) Infanrix Hexa® n (%)

p-value

RR (95%CI)

< 10

35 (31.0)

5 (4.0)

< 0.0001*

7.7 (3.1 – 18.9)

10 – 99

47 (41.6)

22 (17.8)

< 0.0001**

3.3 (2.1 – 4.9)

≥ 100

31 (27.4)

97 (78.2)

-

-

  1. * < 10 vs ≥ 10; ** 10–99 vs ≥ 100